Our findings indicated the importance of Trem2‐Igf1 axis in regulation of microglial activities, particularly those related with microglial glucose metabolism, and further shed light on the therapeutic potentials of targeting microglial immunometabolism in ischemic stroke. The gene discussed is IGF1; the disease is ischemic stroke.